Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirini Vasarmidi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Opinion in Pulmonary Medicine|August 8, 2022
Interstitial lung disease following coronavirus disease 2019Eirini Vasarmidi, Mada Ghanem, Bruno Crestani
Frontiers in Medicine|November 17, 2025
Editorial: Pulmonary involvement in systemic autoimmune rheumatic diseases (SARDs): from diagnostic tools to therapeutic strategiesEirini Vasarmidi, Maria Otaola, Pierre-Antoine Juge
Core Evidence|July 23, 2016
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyGeorge A Margaritopoulos, Eirini Vasarmidi, Katerina M Antoniou
Canadian Respiratory Journal|January 29, 2024
Hypersensitivity Pneumonitis: Challenges of a Complex DiseaseDiana Calaras, Aliona David, Eirini Vasarmidi, et al.
Virus Research|October 20, 2018
Herpes simplex virus type-1 infection affects the expression of extracellular matrix components in human nucleus pulposus cellsKalliopi Alpantaki, Alexandros Zafiropoulos, Melpomeni Tseliou, et al.
Rheumatology Advances in Practice|August 17, 2022
Whatever 'smells' like COVID-19 is not always COVID-19Eirini Vasarmidi, Raphael Hindre, Yurdagül Uzunhan, et al.
Experimental and Therapeutic Medicine|August 9, 2020
Pulmonary fibrosis in the aftermath of the COVID-19 era (Review)Eirini Vasarmidi, Eliza Tsitoura, Demetrios A Spandidos, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Smoking and interstitial lung diseasesGeorge A Margaritopoulos, Eirini Vasarmidi, Joseph Jacob, et al.
The Lancet. Respiratory Medicine|April 3, 2019
Interstitial lung abnormalities: ignotum per ignotiusKaterina M Antoniou, Vasilios Tzilas, Eirini Vasarmidi, et al.
Pulmonology|October 27, 2019
A role of antifibrotics in the treatment of Scleroderma-ILD?Katerina M Antoniou, Athina Trachalaki, Argyris Tzouvelekis, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Opinion in Pulmonary Medicine|August 8, 2022
Interstitial lung disease following coronavirus disease 2019Eirini Vasarmidi, Mada Ghanem, Bruno Crestani
Frontiers in Medicine|November 17, 2025
Editorial: Pulmonary involvement in systemic autoimmune rheumatic diseases (SARDs): from diagnostic tools to therapeutic strategiesEirini Vasarmidi, Maria Otaola, Pierre-Antoine Juge
Core Evidence|July 23, 2016
Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyGeorge A Margaritopoulos, Eirini Vasarmidi, Katerina M Antoniou
Canadian Respiratory Journal|January 29, 2024
Hypersensitivity Pneumonitis: Challenges of a Complex DiseaseDiana Calaras, Aliona David, Eirini Vasarmidi, et al.
Virus Research|October 20, 2018
Herpes simplex virus type-1 infection affects the expression of extracellular matrix components in human nucleus pulposus cellsKalliopi Alpantaki, Alexandros Zafiropoulos, Melpomeni Tseliou, et al.
Rheumatology Advances in Practice|August 17, 2022
Whatever 'smells' like COVID-19 is not always COVID-19Eirini Vasarmidi, Raphael Hindre, Yurdagül Uzunhan, et al.
Experimental and Therapeutic Medicine|August 9, 2020
Pulmonary fibrosis in the aftermath of the COVID-19 era (Review)Eirini Vasarmidi, Eliza Tsitoura, Demetrios A Spandidos, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Smoking and interstitial lung diseasesGeorge A Margaritopoulos, Eirini Vasarmidi, Joseph Jacob, et al.
The Lancet. Respiratory Medicine|April 3, 2019
Interstitial lung abnormalities: ignotum per ignotiusKaterina M Antoniou, Vasilios Tzilas, Eirini Vasarmidi, et al.
Pulmonology|October 27, 2019
A role of antifibrotics in the treatment of Scleroderma-ILD?Katerina M Antoniou, Athina Trachalaki, Argyris Tzouvelekis, et al.
Pageof 5